| 注册
首页|期刊导航|广东药学院学报|我国疫苗安全保障系统的完善——基于上市后安全风险监测视角

我国疫苗安全保障系统的完善——基于上市后安全风险监测视角

张丽杨 颜建周 邵蓉

广东药学院学报2017,Vol.33Issue(3):383-387,5.
广东药学院学报2017,Vol.33Issue(3):383-387,5.DOI:10.16809/j.cnki.2096-3653.2017031401

我国疫苗安全保障系统的完善——基于上市后安全风险监测视角

Improvement of vaccine safety guarantee system in China-based on post-marketing surveillance of vaccine safety

张丽杨 1颜建周 1邵蓉1

作者信息

  • 1. 中国药科大学国家药物政策与医药产业经济研究中心,江苏 南京 211198
  • 折叠

摘要

Abstract

Vaccine safety has been attracted more attentions owing to a series of vaccine safety events,which revealed serious problems existed in supervision system in China.Based on analysis of the causes and problems of two vaccine cases occurred in Shanxi and Shandong,this paper points out the problems existed in post-marketing surveillance of vaccine safety.After analysis of passive and active surveillances of post-marketing vaccine safety in America,this paper also gives a suggestion for improving the vaccine safety system in China from three aspects of prevention,early warning and emergency response.

关键词

疫苗安全/预防/被动监测/主动监测/应急处置

Key words

vaccine safety/prevention/passive surveillance/active surveillance/emergency

分类

医药卫生

引用本文复制引用

张丽杨,颜建周,邵蓉..我国疫苗安全保障系统的完善——基于上市后安全风险监测视角[J].广东药学院学报,2017,33(3):383-387,5.

基金项目

国家社会科学基金项目(15BZZ052) (15BZZ052)

广东药学院学报

OACSTPCD

1006-8783

访问量0
|
下载量0
段落导航相关论文